USE OF HSP90 INHIBITORS TO OVERCOME TRASTUZUMAB RESISITANCE IN THE MINOR VARIANT OF HER2 P95HER2 IN BREAST CANCER

Author/Creator

Author/Creator ORCID

Date

2018-11-30

Department

Department of Biology

Program

Biomedical Science

Citation of Original Publication

Rights

Subjects

Abstract